[The private vaccines market in Brazil: privatization of public health].
The main objective of this article is to analyze the vaccines market in Brazil, which is characterized as consisting of two segments with distinct practices and logics: the public segment, focused on supply within the Unified National Health System (SUS) and the private segment, organized around private clinics, physicians' offices, and similar private health facilities. The private vaccines market segment, studied here for the first time, is characterized in relation to the supply and demand structure. Historical aspects of its structure are analyzed, based on the creation of one of the first immunization clinics in the country. The attempt was to analyze this segment in relation to its economic dimensions (imports and sales), principal manufacturers, and products marketed. It economic size proved much greater than initially hypothesized. The figures allow one to view it as one of the main segments in the pharmaceutical industry in Brazil as measured by sales volume. One detects the penetration of a privatizing logic in a sphere that has always been essentially public, thereby introducing into the SUS a new space for disregarding the principles of equity and universality.
Temporão
José Gomes
JG
Departamento de Administração e Planejamento em Saúde, Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, 21041-210, Brasil. temporao@ensp.fiocruz.br
D001938:Brazil; D004345:Drug Industry / Q000191:economics*; D006297:Health Services Accessibility; D006301:Health Services Needs and Demand; D006801:Humans; D017149:Private Sector; D011332:Privatization; D017150:Public Sector; D014612:Vaccines / Q000191:economics* / Q000600:supply & distribution
D014612:Vaccines